Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes.

Clinical lung cancer - 1 Sept 2016

Naidoo Jarushka, Santos-Zabala Maria L, Iyriboz Tunc, Woo Kaitlin M, Sima Camelia S, Fiore John J, Kris Mark G, Riely Gregory J, Lito Piro, Iqbal Afsheen, Veach Stephen, Smith-Marrone Stephanie, Sarkaria Inderpal S, Krug Lee M, Rudin Charles M, Travis William D, Rekhtman Natasha, Pietanza Maria C

Abstract excerpt

BACKGROUND: Large cell neuroendocrine carcinoma (LCNEC) accounts for approximately 3% of lung cancers. Pathologic classification and optimal therapies are debated. We report the clinicopathologic features, treatment and survival of a series of patients with stage IV LCNEC. MATERIALS AND METHODS: Cases of pathologically-confirmed stage IV LCNEC evaluated at Memorial Sloan Kettering Cancer Center from 2006 to 2013...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Large Cell

Share to Carcinoma, Neuroendocrine

Share to Neoplasm Staging

Share to Proto-Oncogene Proteins p21(ras)

Share to Smoking

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 26898325
DOI: 10.1016/j.cllc.2016.01.003
PMCID: PMC5474315

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes.PMID 26898325Read ↗

The Unmet Diagnostic and Treatment Needs in Large Cell Neuroendocrine Carcinoma of the LungSemantic proximity Read ↗

BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: a case report and review of the literature.Semantic proximity Read ↗

Molecular Pathology of Pulmonary Large Cell Neuroendocrine Carcinoma: Novel Concepts and TreatmentsSemantic proximity Read ↗

Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma.Semantic proximity Read ↗

Esophageal neuroendocrine carcinoma: molecular insights, diagnostic advances, and emerging treatment strategies.Semantic proximity Read ↗

New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impactsSemantic proximity Read ↗

Biology and novel therapeutics for neuroendocrine tumors of the lung.Semantic proximity Read ↗

Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.Semantic proximity Read ↗

Integrated Molecular and Clinical Characterization of Pulmonary Large Cell Neuroendocrine CarcinomaSemantic proximity Read ↗

Beyond Traditional Morphological Characterization of Lung Neuroendocrine Neoplasms: In Silico Study of Next-Generation Sequencing Mutations Analysis across the Four World Health Organization Defined GroupsSemantic proximity Read ↗

The management of extrapulmonary poorly differentiated (high-grade) neuroendocrine carcinomas.Semantic proximity Read ↗

Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.